Injectable
Annual accounts 2025
micro format, filed on 26-01-2026, 5 days before the deadlineTurnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €140,000. Estimated: probably between €110,000 and €180,000.
Balance sheet
balance sheet total €103,753 on 30-06-2025in euro
in euro
Position in the sector
81.1%
Higher than 76% of 21,208 companies in 2025.
5.35
Higher than 77% of 20,571 companies in 2025.
42.1%
Higher than 80% of 20,746 companies in 2025.
Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| Balance sheet: assets | |||
20/58 |
103,753 | 57,749 | |
21/28 |
342 | 648 | |
22/27 |
342 | 648 | |
24 |
342 | 648 | |
29/58 |
103,410 | 57,101 | |
40/41 |
18,866 | 11,815 | |
40 |
18,861 | 11,815 | |
41 |
4 | - | |
54/58 |
82,143 | 43,059 | |
490/1 |
2,401 | 2,227 | |
| Balance sheet: equity and liabilities | |||
10/49 |
103,753 | 57,749 | |
10/15 |
84,153 | 40,448 | |
10/11 |
5,000 | 5,000 | |
14 |
79,153 | 35,448 | |
17/49 |
19,600 | 17,301 | |
42/48 |
19,328 | 17,194 | |
44 |
200 | 730 | |
440/4 |
200 | 730 | |
45 |
18,349 | 16,297 | |
450/3 |
17,099 | 15,097 | |
454/9 |
1,250 | 1,200 | |
47/48 |
779 | 167 | |
492/3 |
272 | 107 | |
| Income statement | |||
9900 |
59,170 | 48,300 | |
630 |
306 | 1,195 | |
640/8 |
2,232 | - | |
9901 |
56,632 | 47,105 | |
75/76B |
219 | 2 | |
75 |
219 | 2 | |
65/66B |
1,570 | 2,167 | |
65 |
1,570 | 2,167 | |
9903 |
55,280 | 44,940 | |
67/77 |
11,575 | 9,493 | |
9904 |
43,705 | 35,448 | |
9905 |
43,705 | 35,448 | |
| Appropriation of the result | |||
9906 |
79,153 | 35,448 | |
14P |
35,448 | - | |
| Document | |||
The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).
Source: Annual accounts 2025 (PDF), filed on 26-01-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankKey figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| 56,938 | 48,300 | ||
| 44,011 | 36,643 | ||
| 0 | 1,843 | ||
| 39,084 | - | ||
| 84,082 | 39,906 | ||
| 81.1% | 70.0% | ||
| 5.35 | 3.32 | ||
| 0.23 | 0.43 | ||
| 51.9% | 87.6% | ||
| 42.1% | 61.4% | ||
| 36.26 | 22.29 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 30-06-2025 | 30-06-2024 |
|---|---|---|
| Tangible fixed assets | - | €917 |
| Intangible fixed assets | - | €926 |
| €306 | €1,195 |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
Insights on Injectable
The operating result for 2025 is 20% higher than in 2024.
Debt's share of the balance-sheet total falls from 30.0% to 18.9%. Equity and debt are higher.